The Waste Watcher cited Horizon’s research on how pharmaceutical companies are responding to the upcoming release of the list of 10 drugs that will be subject to Medicare price negotiations.
Only four months after the IRA was signed into law, Horizon Government Affairs determined that at least 24 companies had decided to stop research and development into new drugs as a result of the provisions of the legislation.